Dopaminergic dysregulation in schizophrenia: A target for new drugs
- 1 September 1986
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 9 (1) , 71-83
- https://doi.org/10.1002/ddr.430090109
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- D-2 dopamine receptors in the frontal cortex of rat and humanLife Sciences, 1985
- Schizophrenia and reduced cyclic AMP production: Evidence for the role of receptor-linked eventsLife Sciences, 1982
- Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in ratsNature, 1980
- Effects of haloperidol and probenecid on plasma and CSF dopamine metabolites in the rhesus monkey (Macacca Mulatta)Life Sciences, 1978
- Muscimol differentially facilitates stereotypy but antagonizes motility induced by dopaminergic drugs: A complex GABA-dopamine interactionLife Sciences, 1978
- Suppression by GABAergic drugs of the locomotor stimulation induced by morphine, amphetamine, and apomorphine: Evidence for both pre- and post-synaptic inhibition of catecholamine systemsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1977
- SCHIZOPHRENIA AND THE LIMBIC SYSTEMThe Lancet, 1974
- Elevation of Plasma Prolactin After Hypophysial Stalk Section in the Rat1Endocrinology, 1973
- On the origin of homovanillic acid (HVA) in the cerebrospinal fluidJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1973
- Behavioral effects of l-Dopa in schizophrenic patientsPsychopharmacology, 1973